Pharmacological activation of the EDA/EDAR signaling pathway restores salivary gland function following radiation-induced damage

Grace Hill, Denis Headon, Zoey I. Harris, Kenneth Huttner, Kirsten H. Limesand

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Radiotherapy of head and neck cancers often results in collateral damage to adjacent salivary glands associated with clinically significant hyposalivation and xerostomia. Due to the reduced capacity of salivary glands to regenerate, hyposalivation is treated by substitution with artificial saliva, rather than through functional restoration of the glands. During embryogenesis, the ectodysplasin/ectodysplasin receptor (EDA/EDAR) signaling pathway is a critical element in the development and growth of salivary glands. We have assessed the effects of pharmacological activation of this pathway in a mouse model of radiation-induced salivary gland dysfunction. We report that post-irradiation administration of an EDAR-agonist monoclonal antibody (mAbEDAR1) normalizes function of radiation damaged adult salivary glands as determined by stimulated salivary flow rates. In addition, salivary gland structure and homeostasis is restored to pre-irradiation levels. These results suggest that transient activation of pathways involved in salivary gland development could facilitate regeneration and restoration of function following damage.

Original languageEnglish (US)
Article number112840
JournalPloS one
Volume9
Issue number11
DOIs
StatePublished - Nov 19 2014

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Pharmacological activation of the EDA/EDAR signaling pathway restores salivary gland function following radiation-induced damage'. Together they form a unique fingerprint.

  • Cite this